Dergiler / Eurasian Journal of Emergency Medicine / 2021 / Cilt: 20 - Sayı: 1

Factors Affecting Prognosis in Patients with Snakebite

Sayfa
6–11
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Hospitalization durations of patients with shorter bite to antivenom infusion intervals (bite-to-needle) were also shorter (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: This study aimed to determine the factors influencing hospitalization durations and discharge status of patients with snakebite, starting from pre-hospital care in the field.Materials and Methods: A total of 38 patients with snakebite admitted to the emergency medicine department between May 1st, 2013 and August 31st, 2016, participated in the study.
📊
Temel Bulgular & Veri:Data were evaluated using Statistical Package for the Social Sciences 17.0.Results: A total of 38 patients were enrolled, of which, 17 (44.7%) were female.
💡
Sonuç & Katkı:Hospitalization durations of patients with shorter bite to antivenom infusion intervals (bite-to-needle) were also shorter (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: This study aimed to determine the factors influencing hospitalization durations and discharge status of patients with snakebite, starting from pre-hospital care in the field.Materials and Methods: A total of 38 patients with snakebite admitted to the emergency medicine department between May 1st, 2013 and August 31st, 2016, participated in the study. Data were evaluated using Statistical Package for the Social Sciences 17.0.Results: A total of 38 patients were enrolled, of which, 17 (44.7%) were female. Of the 38 patients enrolled, nine patients were in stage 1, 24 in stage 2, and 5 in stage 3. The mean antivenoms given to patients were 3.33±1.29 vials in stage 2 and 4.40±1.14 vials in stage 3. The mean time from bite to antivenom infusion was 80.92±47.57 mins. Hospitalization durations of patients with shorter bite to antivenom infusion intervals (bite-to-needle) were also shorter (p

🔖

Bu Makaleye Atıf Yap

Ozbulat, M., Acikalin, A., Akday, U., Taşkın, Ö., Dişel, N. R., SEBE, A. (2022). Factors Affecting Prognosis in Patients with Snakebite. Eurasian Journal of Emergency Medicine, Cilt: 20 - Sayı: 1, 6–11. https://ajindex.com/articles/507915

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLOS Medicine. 2008;5:e218
  2. Mohapatra B, Warrell D, Bhatia P, Dhingra N, Jotkar R, Rodriguez P, et al. snakebite mortality in India: a nationally representative mortality survey. PLoS Negl Trop Dis. 2011;5:e1018
  3. Forrester JD, Forrester JA, Tennakoon L, Staudenmayer K. Mortality, hospital admission, and healthcare cost due to injury from venomous and nonvenomous animal encounters in the USA: 5-year analysis of the National Emergency Department Sample. Trauma Acute Care Surg. 2018;3:e000250
  4. Cesaretli Y, Ozkan O. Snakebites in Turkey: epidemiological and clinical aspects between the years 1995 and 2004. J Venom Anim Toxins Incl Trop Dis. 2010;16:579-86
  5. Riley BD PA, Ruha AM. Snakes and Other Reptiles. In: Goldfrank LR NL, Lewin NA, Howland MA, Hoffman RS, Flomenbaum NE, editor. Goldfrank’s Toxicologic Emergencies. 9th ed: New York: Mc Graw-Hill Medical; 2011. p. 1604
  6. Wagener M, Naidoo M, Aldous C. Wound infection secondary to snakebite. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2017;4:315-9
  7. Banda C, N’gambi C. Necrotizing fasciitis with mediastinitis following snakebite envenomation. SAGE Open Med Case Rep. 2019;7:2050313X1882309
  8. Ribeiro L, Jorge M, Lebrão M. Prognostic factors for local necrosis in Bothrops jararaca (Brazilian pit viper) bites. Trans R Soc Trop Med Hyg. 2001;95:630-4
  9. Cheng A, Currie B. Venomous snakebites worldwide with a focus on the australia-pacific region: current management and controversies. J Intensive Care Med. 2004;19:259-69
  10. Currie B. Treatment of snakebite in Australia: The current evidence base and questions requiring collaborative multicentre prospective studies. Toxicon. 2007;48:941-56
  11. Suchithra N, Pappachan J, Sujathan P. Snakebite envenoming in Kerala, South India: Clinical profile and factors involved in adverse outcomes. EMJ. 2008;25:200-4 12. Grupper M, Nicolau D. Obesity and skin and soft tissue infections: how to optimize antimicrobial usage for prevention and treatment? Curr Opin Infect Dis. 2017;30:1
  12. Sharma S, Chappuis F, Jha N, Bovier P, Loutan L, Koirala S. Impact of snake bites and determinants of fatal outcomes in Southeastern Nepal. Am J Trop Med Hyg. 2004;71:234-8
  13. Açıkalın A, Gökel Y, Kuvandık G, Duru M, Köseoğl